Related Experiment Video
Updated: Aug 15, 2025

07:34
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
19.5K
Functionalized core-shell nanogel scavenger for immune modulation therapy in sepsis
Xiaotian Ji1, Xiguang Yang1, Changying Shi1
1Department of Pharmacology, State University of New York Upstate Medical University, Syracuse, NY 13210, United States.
Advanced Therapeutics
|January 2, 2023
Summary
A novel core-shell hydrogel nanoparticle, functionalized with telodendrimer nanotrap, effectively controls sepsis-induced hyperinflammation by selectively removing harmful molecules and cytokines. This innovative nanogel shows promise for treating sepsis and other inflammatory conditions.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Immunology
Background:
- Sepsis is a life-threatening condition characterized by hyperinflammation, organ failure, and high mortality.
- Current treatment options for sepsis are limited, highlighting the need for novel therapeutic strategies.
- Hyperinflammation in sepsis involves the overproduction of pro-inflammatory cytokines and the presence of endotoxins like lipopolysaccharides (LPS).
Purpose of the Study:
- To develop and evaluate a core-shell hydrogel nanoparticle functionalized with telodendrimer (TD) nanotrap (NT) for controlling sepsis-induced hyperinflammation.
- To investigate the nanoparticle's ability to selectively scavenge inflammatory molecules and cytokines.
- To assess the therapeutic efficacy of the TD NT nanogel in preclinical models of sepsis.
Main Methods:
- Synthesis of a core-shell hydrogel nanoparticle with a TD-functionalized core and a crosslinked shell.
- Characterization of the nanoparticle's size-selective scavenging properties for molecules like LPS and cytokines.
- In vitro and in vivo evaluation of the TD NT nanogel's efficacy in reducing inflammation markers (e.g., cytokine production, NF-κB activation) in LPS-induced sepsis models.
Main Results:
- The TD NT nanogel demonstrated size-selective scavenging, excluding large proteins while capturing medium-sized molecules (10-30 kDa) like LPS.
- The nanogel effectively captured pro-inflammatory cytokines both in vitro and in vivo.
- Intraperitoneal administration of the TD NT nanogel significantly attenuated NF-κB activation and cytokine production in septic mouse models.
Conclusions:
- The core-shell TD NT nanogel is a promising therapeutic agent for controlling hyperinflammation in sepsis.
- The nanoparticle's ability to selectively remove inflammatory mediators offers a novel approach to sepsis treatment.
- Injectable TD NT core-shell nanogels have potential applications in attenuating both local and systemic inflammation.
Keywords:
core-shell nanogelcytokine adsorptionendotoxin removalimmune modulationsepsis treatmentsize-exclusivetelodendrimer nanotrap
